ClinicalTrials.gg
DrugRead study by study

Abemaciclib clinical trials

Also written LY2835219 and Verzenio.

studies test it
157
open now
51
in phase 3
15
first study started
2009
ClinicalTrials.gov finds 297 studies for abemaciclib. How that becomes 157 here

Every study that search finds has been read, apart from the 1 newest, to see whether and how it gives abemaciclib. ClinicalTrials.gov counts as of Nov 15, 2026. How drug pages count

  1. 297Found by its intervention search · See all 297 hereIt also reads titles, arm labels, keywords and descriptions, and counts the drug’s other names. Of these, 246 name it in an intervention entry. The counts it shows beside each synonym overlap: a study writing two names counts under both.
  2. 297Give abemaciclib to participants
  3. −36Observe patients on it, or give it outside a trial
  4. −4Use it as a tool: an imaging tracer or a test of drug response
  5. −8Compare another treatment with it
  6. −92Give it beside what is tested
  7. 157Test it: the count on this site

Get an email when these change. Save the abemaciclib studies recruiting or about to start — once a week, free: studies that open, close, add sites or post results.

Get alerts for these studies
See an example email

Example · made-up studies

Breast cancer · Recruiting: 2 came in, 3 changed

What changed in your alerts, Oct 31 – Nov 6:

A study of drug A after surgery for early breast cancer

Came in · now Recruiting

Drug B with hormone therapy in advanced breast cancer

Changed

· Sites: 4 added, including Seoul and Busan

· Enrollment: 300 → 450 participants

Exercise during chemotherapy

Now Active, not recruiting

One email a week for all your alerts. Stop any time.

Approvals

The first approval found in each region, with its record

United States
28 Sept 2017 · VERZENIO · NDA 208716 (FDA, Drugs@FDA)
European Union
26 Sept 2018 · Verzenios · EMEA/H/C/004302 (EMA)

From FDA's Drugs@FDA and Purple Book (through openFDA) and the European Medicines Agency, files of Sept 2026 and 27 Oct 2026. National approvals in Europe and other countries are not included. How this is worked out

How studies write it

Studies that test it under each name

Name

Abemaciclib
131
Verzenios
8
Abemaciclib 200 MG
2
Abemaciclib Tablet (Test Formulation)
2
Abemaciclib 150 MG Oral Tablet
2

Brand

Verzenio
35

Development codes

LY2835219
68

Studies by the year they started

157 studies that test it; most in 2020 (21)

Studies that test abemaciclib, by start year
YearStudies
20091
20133
20149
20158
201612
201711
20186
201919
202021
202121
20226
20238
202412
20258
202612

By phase

A phase 1/2 study counts in both.

Early Phase 1
5
Phase 1
49
Phase 2
93
Phase 3
15
Phase 4
9
No phase
1

What it is tested for

Each study’s main condition, where its own words name it, so a study counts once.

Who runs them

Industry 50 · Other 107

Eli Lilly and Company (49) · Dana-Farber Cancer Institute (11) · Memorial Sloan Kettering Cancer Center (7) · National Cancer Institute (NCI) (6) · Fudan University (3) · Alliance for Clinical Trials in Oncology (2) · University of Washington (2) · OHSU Knight Cancer Institute (2)

Often tested with

Tested in the same studies.

Letrozole (10) · Fulvestrant (7) · Anastrozole (6) · Temozolomide (5) · Palbociclib (5) · Ribociclib (4) · Aromatase inhibitors (4) · Ramucirumab (3)

Related medicines

As reviewed, each with the page that says it.

Coming up

From the study records. Dates are the sponsors’ own estimates and often move.

Tested against it · 2 phase 3 studies under way

Abemaciclib is the comparator. A study of two new drugs counts under both.

New treatments tested with it · 8 most studied

New when their studies opened, with abemaciclib beside them; studies of each.

Reaching primary completion within a year · 28, 1 in phase 3

Studies that test abemaciclib, phase 3 first.

Studies

Open first, then newest update. How each study uses abemaciclib has had a first review, but it may not be perfect: check the study record before relying on it for anything important, and report a problem from its row. Some give it without naming it in an intervention entry: those were found by reading the record.

Testing it · 157

See all 157 studies that test abemaciclib →

Behind its US label · 4 — the studies the FDA label of VERZENIO describes

From the Clinical Studies section of VERZENIO (2026-07), as openFDA has it. A study the site does not hold is left out.

Tested on its own · 45 — no other medicine in its arm

Showing 20 of 45. See all 45 →

Tested with established drugs · 29 — they are given beside it

Showing 20 of 29. See all 29 →

Tested in a combination · 83 — another drug in the study is under test too

Showing 20 of 83. See all 83 →

Beside an established treatment under test · 5 — an approved drug, surgery or radiation is what the study tests

Tested with abemaciclib: copanlisib hydrochloride 1 · Surgery or a procedure 1 · palbociclib 1 · ribociclib 1 · Anastrozole 1 · exemestane 1 · Radiation 1 · Hydroxychloroquine 1

Beside a new treatment under test · 56 — a new drug, cell therapy or vaccine is what the study tests

New treatments tested with abemaciclib: giredestrant 5 · inavolisib 5 · LY3214996 4 · ipatasertib 4 · vepdegestrant 2 · AZD9833 2 · capivasertib 2 · Imlunestrant 2

Showing 20 of 56. See all 56 →

Beside supportive care · 8 — a supportive treatment or test is studied
One option of several · 23 — a test or a strategy chooses among drugs

Showing 20 of 23. See all 23 →

As the comparator · 8 — what is tested is compared with abemaciclib
Observed · 36 — patients on it are followed, or it is given outside a trial

Showing 20 of 36. See all 36 →

As a tool · 4 — an imaging tracer or a test of drug response

What changed recently

From the registry's own updates since Oct 17, 2026.

Codes

What other systems call abemaciclib · ClinicalTrials.gg INT000043

  • MeSH (NLM) C000590451abemaciclibConfirmed ClinicalTrials.gov, NLM
  • UNII (FDA) 60UAB198HKABEMACICLIBConfirmed FDA, NLM, Wikidata
  • RxNorm 1946825Confirmed FDA, Wikidata
  • Wikidata Q23901483abemaciclibConfirmed FDA, NLM, Wikidata
  • NCI Thesaurus C97660AbemaciclibOne source FDA
  • DrugBank DB12001One source Wikidata

Also registered as abemaciclib mesylate (UNII KKT462Q807).

“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.

Start the discussion